During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Scottish people celebrate the birthday of national writer Robert Burns with events including haggis throwing and the Big Burns Supper.
There will be a rare chance to see an asteroid pass so close to the Earth you will be able to see it with binoculars on Monday night.
A cold front is sinking its way southwards tonight and bringing steady rainfall for some parts of the UK.